Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice

  • 0Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, 430072, China.

|

|

Summary

This summary is machine-generated.

Breast cancer cells release microRNAs (miRNAs) in extracellular vesicles (EVs) that promote liver metastasis by altering cholesterol metabolism. Inhibiting these miRNAs or specific enzymes prevents metastasis in mice.

Area Of Science

  • Oncology
  • Molecular Biology
  • Metabolism

Background

  • Extracellular vesicles (EVs) mediate intercellular communication and are implicated in tumor progression and metastasis.
  • Tumor metastasis is often associated with dysregulated cholesterol metabolism, but the role of EVs in cholesterol homeostasis remains unclear.

Purpose Of The Study

  • To investigate the role of breast cancer-derived EVs in regulating cholesterol homeostasis during liver metastasis.
  • To identify specific molecular mechanisms by which EVs influence metastasis-associated metabolic changes.

Main Methods

  • Analysis of microRNA (miR-9-5p) content in breast cancer-derived exosomes.
  • In vitro studies targeting INSIG1, INSIG2, and ATF3 genes.
  • In vivo mouse models of breast cancer liver metastasis.
  • In vivo antagomir treatment and genetic ablation of CH25H.

Main Results

  • Breast cancer exosomal miR-9-5p upregulates HMGCR and CH25H liver enzymes by targeting INSIG1, INSIG2, and ATF3.
  • miR-9-5p promotes cholesterol synthesis and 25-hydroxycholesterol conversion.
  • In vivo inhibition of miR-9-5p or CH25H significantly reduced liver metastasis in mice.

Conclusions

  • Tumor-derived exosomal miR-9-5p plays a critical role in liver metastasis by modulating cholesterol metabolism and Kupffer cell polarization.
  • Targeting exosomal miRNAs and related metabolic pathways offers potential therapeutic strategies for preventing cancer metastasis.